Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-U
2024-517236-22-00Phase 3Authorised
- Sponsor
- Heidelberg University
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of aspirin in brain aneurysm (IA), sponsored by Heidelberg University. Planned start Nov 2024; status: authorised.
02
Drugs
aspirin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on 2024-517236-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517236-22-00.